证券记录 · 已归档季度
CAPR
Capricor Therapeutics, Inc. · Healthcare · Biotechnology
11被追踪持有人
+1Δ持有人
8.31M持有股份
$82.57M报告持仓市值
+2新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +10.0% ·
股份流向 -7.1% ·
净新建仓位 +9.1%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -1 | 21.29M | $513.07M | +4 | −5 |
| Q1 2026 | 74 | +11 | 17.90M | $543.13M | +17 | −6 |
| Q4 2025 | 63 | 0 | 16.01M | $462.15M | +1 | −1 |
| Q3 2025 | 17 | +3 | 9.08M | $65.46M | +3 | — |
| Q2 2025 | 11 | +1 | 8.31M | $82.57M | +2 | −1 |
| Q1 2025 | 7 | -3 | 3.63M | $34.48M | — | −3 |
| Q4 2024 | 10 | +4 | 3.77M | $51.99M | +5 | −1 |
| Q3 2024 | 5 | -1 | 1.06M | $16.12M | +2 | −3 |
| Q2 2024 | 6 | — | 1.44M | $6.86M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 2.98M | — | $29.63M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 2.31M | — | $22.89M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 2.31M | — | $22.89M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 2.31M | — | $22.89M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (被动) | 2.31M | — | $22.89M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (被动) | 2.31M | — | $22.89M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | State Street Global Advisors ✦ (被动) | 1.47M | -20.4% | $14.56M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Geode Capital Management ✦ (被动) | 963.08K | +6.8% | $9.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Geode Capital Management ✦ (被动) | 963.08K | +6.8% | $9.56M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Millennium Management ✦ | 173.85K | -21.7% | $1.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 155.84K | +24.7% | $1.55M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Wellington Management ✦ | 131.88K | +19.1% | $1.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 22 | Wellington Management ✦ | 131.88K | +19.1% | $1.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Wellington Management ✦ | 131.88K | +19.1% | $1.31M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | Marshall Wace ✦ | 80.19K | 新增 | $796,257 | 0.0% | New | 1 | SEC ↗ |
| 25 | Marshall Wace ✦ | 80.19K | 新增 | $796,257 | 0.0% | New | 1 | SEC ↗ |
| 26 | Fidelity (FMR) ✦ | 24.19K | — | $240,206 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Fidelity (FMR) ✦ | 24.19K | — | $240,206 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 19.02K | +22.5% | $189,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 29 | D. E. Shaw & Co. ✦ | 10.73K | 新增 | $106,579 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Marshall Wace | $796,257 | 0.0% |
| Marshall Wace | $796,257 | 0.0% |
| D. E. Shaw & Co. | $106,579 | 0.0% |
已清仓
| Citadel Advisors | $3.95M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 176 持有人, 33.48M 股份, $1.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据